Mr. Speaker, the problem is that this issue relates to the CETA, not the provinces. If this is the government's idea of defending the interests of Canadians, so much for that.
We will have to spend an estimated $2.8 billion more a year on drugs if Canada signs this agreement with the EU, and Canadians will receive nothing in return: no access to better drugs, generic drugs or low prices.
Why is the minister taking this file so lightly without showing any leadership? Why is she defending large pharmaceutical companies instead of Canadians?